Answers are grounded in this paper and cite their sources.
Bone tissue engineering requires three-dimensional scaffolds that mimic the extracellular matrix, support cell behavior, and degrade at an appropriate rate. This study fabricated polylactic acid/polycaprolactone/hydroxyapatite (PLA/PCL/HA) composite scaffolds via solvent casting/particle leaching and systematically investigated the effects of PLA:PCL weight ratios (0:100, 25:75, 50:50, 75:25, 100:0) and HA concentrations (1, 3, and 5 wt%) on wettability, biodegradability, bioactivity, cytocompatibility, and osteogenic potential. Results demonstrated that increasing PLA content in the PLA/PCL blend had only a modest effect on hydrophilicity, with contact angles of unfilled scaffolds remaining in the range of approximately 110–113° due to the polar ester groups of PLA. In contrast, the incorporation of HA nanoparticles markedly improved wettability through both chemical (polar hydroxyl and phosphate groups) and physical (surface roughening) mechanisms, reducing the contact angle from 112.76° (pure PCL) to 84.34° for the 75PLA/25PCL-5HA formulation. Bioactivity assessment in simulated body fluid for 28 days showed calcium phosphate layer formation on all HA-containing scaffolds. The 75PLA/25PCL-5HA and 50PLA/50PCL-5HA samples achieved Ca/P atomic ratios of 1.77 and 1.58, respectively, both of which fall within the apatite range and are close to the stoichiometric HA value of 1.67 (deviations of 0.10 and 0.09, respectively). MTT assays showed maintained MG-63 cell metabolic activity across all scaffold formulations during the 7-day culture period MTT assays showed maintained MG-63 cell metabolic activity across all scaffold formulations during the 7-day culture period. Alizarin Red staining demonstrated that HA-containing scaffolds significantly promoted calcium deposition compared to HA-free samples, with the 75PLA/25PCL-5HA sample exhibiting the highest mineralization capacity. These findings establish that PLA/PCL/HA composite scaffolds fabricated by solvent casting/particle leaching, particularly the 75PLA/25PCL-5HA formulation, represent promising candidates for bone tissue regeneration applications.
No takes yet. Share an insight, caveat, or question.
Nazari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: